Published • loading... • Updated
Alzheimer's Disease Blood Biomarkers Increase up to 95% Faster in Obese Individuals
Obesity accelerates Alzheimer's blood biomarker increases by up to 95%, suggesting faster disease progression, based on five-year data from 407 participants in the Alzheimer's Disease Neuroimaging Initiative.
- On Dec. 2, 2025, researchers presented at the Radiological Society of North America that blood-based biomarkers rose up to 95% faster in people with obesity than in non-obese individuals.
- Researchers analyzed five-year ADNI data from 407 participants, testing plasma pTau217, neurofilament light chain and GFAP with six leading commercial tests, validating BBMs against amyloid PET and using statistical models assessing BMI-time-BBM interactions.
- At baseline, body mass index correlated with lower blood biomarkers and reduced whole‑brain amyloid burden, but obesity led to a 24% faster plasma neurofilament light chain increase and 3.7% faster amyloid accumulation.
- Implications for clinical practice include obesity being a potential risk factor, with Dr. Raji noting `this is the first time we've shown the relationship between obesity and Alzheimer's disease as measured by blood biomarker tests.`
- Caution is advised because results remain preliminary until peer‑reviewed publication; Raji expects longitudinal blood biomarkers and brain imaging will monitor patients on anti‑amyloid drugs, while trials could test obesity/weight‑loss drugs.
Insights by Ground AI
21 Articles
21 Articles
Blood test shows obesity speeds Alzheimer's development
Researchers have conducted the first study evaluating the impact of obesity on Alzheimer's disease blood biomarkers (BBMs). BBM values increased up to 95% faster in individuals with obesity than in non-obese individuals, according to a study presented at the annual meeting of the Radiological Society of North America (RSNA).
Coverage Details
Total News Sources21
Leaning Left3Leaning Right4Center7Last UpdatedBias Distribution50% Center
Bias Distribution
- 50% of the sources are Center
50% Center
L 21%
C 50%
R 29%
Factuality
To view factuality data please Upgrade to Premium














